Relationship of androgenic alopecia with higher BMI in Pakistan: A cross sectional study
DOI:
https://doi.org/10.66344/jpad.31.1.2021.1526Keywords:
Androgenetic, Alopecia, BMI, MetabolicAbstract
Objective  To determine the relationship of higher basal metabolic index (BMI) with severity of androgenic alopecia.  Methods  A hospital-based analytical cross-sectional study was done in men in the age group of 17-55 year. Weight and height were taken to determine BMI and Norwood scale was used to grade AGA.  Results  In this cross sectional study a total of 246 participants were included. Majority of them were (69.90%) of 31-40 years. Most of the men (45.10%) were in severe stage (6,7) of alopecia trailed by (43.09%) those having moderate stage (3,4,5). Most of them (62.60%) having AGA were obese (BMI > 30). Conclusion  Patients with severe AGA were significantly and strongly associated with higher BMI.References
References:
Yang CC, Hsieh FN, Lin LY, Hsu CK, Sheu HM, Chen W. Higher body mass index is associated with greater severity of alopecia in men with male-pattern androgenetic alopecia in Taiwan: a cross-sectional study. J Am AcadDermatol. 2014 Feb;70(2):297-302.
Yim, Elizabeth; Nole, Katherine L. Baquerizo; Tosti, Antonella (December 2014). "5α-Reductase inhibitors in androgenetic alopecia." Current Opinion in Endocrinology, Diabetes and Obesity. 2014 Dec. 21 (6): 493–498.
Stough D, Stenn K, Haber R, et al. Psychological effect, pathophysiology, and management of androgenetic alopecia in men. Mayo Clin Proc. 2005 Oct. 80(10):1316-22.
Yim E, Nole KL, Tosti A. 5α-Reductase inhibitors in androgenetic alopecia.CurrOpinEndocrinol Diabetes Obes. 2014 Dec;21(6):493-8.
Gok SO, Belli AA, Dervis E. Is There Really Relationship between Androgenetic Alopecia and Metabolic Syndrome?. Dermatology Research and Practice.2015:1-4.
Grover S. A study of patterns of androgenetic alopecia in men: an Indian perspective. Br J Dermatol. 2005;152(3):572-4.
Yi SM, Son SW, Lee KG, Kim SH, Lee SK, Cho ER et al. Gender-Specific Association of Androgenetic Alopecia With Metabolic Syndrome in a Middle-aged Korean Population. Br J Dermatol. 2012 Aug;167(2):306-13.
Hirsso P1, Laakso M, Matilainen V, Hiltunen L, Rajala U, Jokelainen J,et al. Association of insulin resistance linked diseases and hair loss in elderly men. Finnish population-based study. Cent Eur J Public Health. 2006 June; 14(2):78–81.
Lotufo PA1, Chae CU, Ajani UA, Hennekens CH, Manson JE. Male pattern baldness and coronary heart disease: the Physicians' Health Study. Arch Intern Med. 2000 Jan; 160(2).165–71.
Nanan D.J. The Obesity Pandemic - Implications for Pakistan. J Pak Med Assoc. 2002 Aug;52(8):342-6.
Norwood OT. Male pattern baldness: Classification and incidence. South Med J. 1975Nov;68(11):1359–70.
Hirsso P1, Laakso M, Matilainen V, Hiltunen L, Rajala U, Jokelainen J, et al. Association of insulin resistance linked diseases and hair loss in elderly men. Finnish population-based study. Cent Eur J Public Health. 2006 June; 14(2):78–81.
Matilainen V, Koskela P, Keinanen-Kiukaanniemi S. Early androgenetic alopecia as a marker of insulin resistance. Lancet 2000; 356(9236):1165–6.
Ahouansou S, Le Toumelin P, Crickx B, Descamps V. Association of androgenetic alopecia and hypertension. Eur J Dermatol 2007; 17(3):220–2.
Hirsso P1, Rajala U, Hiltunen L, Jokelainen J, Keinänen-Kiukaanniemi S, Näyhä S.. Obesity and low-grade inflammation among young Finnish men with early-onset alopecia. Dermatology 2007; 214(2):125–9.
Downloads
Published
How to Cite
Issue
Section
License
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
